Publication:
Uric acid levels in sera from patients with multiple sclerosis

dc.contributor.authorDrulović, Jelena (55886929900)
dc.contributor.authorDujmović, Irena (6701590899)
dc.contributor.authorStojsavljević, Nebojša (6603086728)
dc.contributor.authorMesarosň S. (15851472200)
dc.contributor.authorAndjelković, Slobodanka (15850349800)
dc.contributor.authorMiljković, Djordje (7006524033)
dc.contributor.authorPerić, Vesna (8368352600)
dc.contributor.authorDragutinović, Gradimir (6507159141)
dc.contributor.authorMarinković, Jelena (7004611210)
dc.contributor.authorLević, Zvonimir (7003341242)
dc.contributor.authorStojković, Marija Mostarica (6701741422)
dc.date.accessioned2025-06-13T00:50:30Z
dc.date.available2025-06-13T00:50:30Z
dc.date.issued2001
dc.description.abstractThe levels of uric acid (UA), a natural peroxynitrite scavenger, were measured in sera from 240 patients with multiple sclerosis (MS) and 104 sex- and age-matched control patients with other neurological diseases (OND). The mean serum UA concentration was lower in the MS than in the OND group, but the difference did not reach the level of statistical significance (P=0.068). However, the mean serum UA level from patients with active MS (202.6+67.1 μmol/l) was significantly lower than that in inactive MS patients (226.5+78.6 μmol/l; P=0.046) and OND controls (P=0.007). We found a significant inverse correlation of serum UA concentration with female gender (P=0.0001), disease activity (P=0.012) and duration (P=0.017), and a trend towards an inverse correlation with disability as assessed by EDSS score, which did not reach statistical significance (P=0.067). Finally, multivariate linear regression analyses showed that UA concentration was independently correlated with gender (P=0.0001), disease activity (P=0.014) and duration of the disease (P=0.043) in MS patients. These findings suggest that serum UA might serve as a possible marker of disease activity in MS. They also provide support to the potential beneficial therapeutic effect of radical-scavenging substances in MS.
dc.identifier.urihttps://doi.org/10.1007/s004150170246
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0035078061&doi=10.1007%2fs004150170246&partnerID=40&md5=b23887eda4df6f4683b4d84959256ee1
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/11281
dc.subjectDisease activity
dc.subjectMagnetic resonance imaging
dc.subjectMultiple sclerosis
dc.subjectPeroxynitrite
dc.subjectUric acid
dc.titleUric acid levels in sera from patients with multiple sclerosis
dspace.entity.typePublication

Files